News-Medical.Net on MSN
Reprogramming immunity to protect beta cells in type 1 diabetes
In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...
As of Friday, January 09, Enlivex Therapeutics Ltd.’s ENLV share price has surged by 5.02%, which has investors questioning ...
Researchers developed a way to directly reprogram human glial cells into PV interneurons without passing through a stem‑cell stage.
Remains on track to name a development candidate for a novel first-in-class neurology program targeting demyelinating diseases in 2026Progresses discovery work on a best-in-class cell therapeutic ...
As the “Predictability Era” Ends, Global Summits, Corporate Conferences, and Boards Turn to Spitz’s “Operating System” ...
Members of the Carbondale community gathered on Friday, Jan. 9 to remember the life of Renee Nicole Good, a 37-year-old woman ...
STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, ...
News-Medical.Net on MSN
Low-dose megestrol strengthens hormone therapy in ER-positive breast cancer
Low-dose megestrol enhances hormone therapy for ER-positive breast cancer, reducing tumor proliferation and improving ...
The federal government has proposed updates to Canada's Motor Vehicle Safety Regulations (MVSR) to improve vehicle security ...
The federal government has proposed updates to Canada's Motor Vehicle Safety Regulations (MVSR) to improve vehicle security ...
Congress has unveiled a new package of bills to fund some agencies through fiscal 2026, the latest bipartisan breakthrough as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback